Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

September 24, 2014 10:45 ET | Source: VBI Vaccines, Inc.

VBI to Present at the CMV Public Health & Policy Conference

VBI is developing a prophylactic CMV vaccine; VBI's Senior Vice President of Research will discuss the vaccine candidate's design, preclinical data, and manufacturing process. The...
September 15, 2014 12:30 ET | Source: VBI Vaccines, Inc.

New Data Supporting VBI's Prophylactic Cytomegalovirus (CMV) Vaccine Candidate (VBI-1501A) Presented at the 54th ICAAC Conference in Washington, D.C.

Rapid, potent, and durable immunity demonstrated with vaccine candidate (VBI-1501A). Pilot scale (10L) production of VBI-1501A expected to meet Phase I trial release criteria. CAMBRIDGE,...
July 28, 2014 08:32 ET | Source: VBI Vaccines, Inc.

Variation Biotechnologies and Paulson Capital Announce Completion of Merger

Paulson Capital (Delaware) Corp. Changes Name to VBI Vaccines Inc. VBI Vaccines Inc. Shares to Trade on NASDAQ Under the Ticker Symbol "VBIV" at Market Open on Tuesday, July 29,...
July 15, 2014 17:12 ET | Source: VBI Vaccines, Inc.

Paulson Capital Announces Stockholder Approval of Contemplated Merger With Variation Biotechnologies (US)

PORTLAND, Ore., July 15, 2014 (GLOBE NEWSWIRE) -- On July 14, 2014, Paulson Capital (Delaware) Corp. (Nasdaq:PLCC) (the "Company") held a Special Meeting of Stockholders at which 67.4% of the...
June 24, 2014 16:50 ET | Source: VBI Vaccines, Inc.

Paulson Capital (Delaware) Corp. Announces Meeting Date and Record Date for the Special Meeting of Stockholders

PORTLAND, Ore., June 24, 2014 (GLOBE NEWSWIRE) -- Paulson Capital (Delaware) Corp. (Nasdaq:PLCC) ("Paulson") today announced that a Special Meeting of Stockholders will be held on July 14, 2014, at...
May 09, 2014 08:30 ET | Source: VBI Vaccines, Inc.

Paulson Capital and Variation Biotechnologies Enter Into Merger Agreement

PORTLAND, Ore., May 9, 2014 (GLOBE NEWSWIRE) -- Paulson Capital (Delaware) Corp., a publicly traded Delaware corporation (Nasdaq:PLCC) ("Paulson"), and privately owned Variation Biotechnologies (US),...
February 20, 2014 09:00 ET | Source: VBI Vaccines, Inc.

Paulson Capital Corp. to Remain Listed on NASDAQ; Receives Letter of Reprimand

PORTLAND, Ore., Feb. 20, 2014 (GLOBE NEWSWIRE) -- Paulson Capital Corp. (Nasdaq:PLCC) (the "Company") today announced that on February 19, 2014, it was notified that, following a hearing on February...
January 28, 2014 17:00 ET | Source: VBI Vaccines, Inc.

Paulson Capital Corp. Announces Changes to Its Board of Directors

PORTLAND, Ore., Jan. 28, 2014 (GLOBE NEWSWIRE) -- Paulson Capital Corp. (Nasdaq:PLCC) (the "Company") today announced the appointment of Alan P. Timmins to its Board and Audit Committee. Mr. Timmins...
January 06, 2014 17:59 ET | Source: VBI Vaccines, Inc.

Paulson Capital Corp. Announces Shares to Resume Trading Pending Hearing Disposition; Issuance of and Intention to Appeal NASDAQ Determination Letter; and Appointment of Independent Director

PORTLAND, Ore., Jan. 6, 2014 (GLOBE NEWSWIRE) -- Paulson Capital Corp. (Nasdaq:PLCC) (the "Company") today announced that it is expected that, effective on January 8, 2014, the Company's common stock...
September 27, 2013 13:32 ET | Source: VBI Vaccines, Inc.

Paulson Capital Corp. Announces Meeting Date and Record Date for the 2013 Annual Meeting of Shareholders

PORTLAND, Ore., Sept. 27, 2013 (GLOBE NEWSWIRE) -- Paulson Capital Corp. (Nasdaq:PLCC) (the "Company") today announced that its 2013 Annual Meeting of Shareholders will be held on November 8, 2013....

keyboard_arrow_left Previous Page

Next Page keyboard_arrow_right